Copyright Reports & Markets. All rights reserved.

Global Phage Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Phage Therapy Market Overview

    • 1.1 Product Overview and Scope of Phage Therapy
    • 1.2 Classification of Phage Therapy by Types
      • 1.2.1 Global Phage Therapy Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Phage Therapy Revenue Market Share by Types in 2018
      • 1.2.3 Oral
      • 1.2.4 External Application
      • 1.2.5 Surgical Treatment
    • 1.3 Global Phage Therapy Market by Application
      • 1.3.1 Global Phage Therapy Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Human Medicine
      • 1.3.3 Veterinary Science
      • 1.3.4 Agriculture
    • 1.4 Global Phage Therapy Market by Regions
      • 1.4.1 Global Phage Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Phage Therapy Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Phage Therapy Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Phage Therapy Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Phage Therapy Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Phage Therapy Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Phage Therapy (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Phage International
      • 2.1.1 Business Overview
      • 2.1.2 Phage Therapy Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Phage International Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Adaptive Phage Therapeutics
      • 2.2.1 Business Overview
      • 2.2.2 Phage Therapy Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 AmpliPhi Biosciences
      • 2.3.1 Business Overview
      • 2.3.2 Phage Therapy Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 AmpliPhi Biosciences Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 C3J Therapeutics
      • 2.4.1 Business Overview
      • 2.4.2 Phage Therapy Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 C3J Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Enbiotix
      • 2.5.1 Business Overview
      • 2.5.2 Phage Therapy Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Enbiotix Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 InnoPhage
      • 2.6.1 Business Overview
      • 2.6.2 Phage Therapy Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 InnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 iNtODEWorld
      • 2.7.1 Business Overview
      • 2.7.2 Phage Therapy Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 iNtODEWorld Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Intralytix
      • 2.8.1 Business Overview
      • 2.8.2 Phage Therapy Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Locus Biosciences
      • 2.9.1 Business Overview
      • 2.9.2 Phage Therapy Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Locus Biosciences Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Phagomed
      • 2.10.1 Business Overview
      • 2.10.2 Phage Therapy Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Phagomed Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Pherecydes Pharma
      • 2.11.1 Business Overview
      • 2.11.2 Phage Therapy Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 TechnoPhage
      • 2.12.1 Business Overview
      • 2.12.2 Phage Therapy Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Eligo Bioscience
      • 2.13.1 Business Overview
      • 2.13.2 Phage Therapy Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Eligo Bioscience Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Phagelux
      • 2.14.1 Business Overview
      • 2.14.2 Phage Therapy Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Phage Therapy Market Competition, by Players

    • 3.1 Global Phage Therapy Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Phage Therapy Players Market Share
      • 3.2.2 Top 10 Phage Therapy Players Market Share
    • 3.3 Market Competition Trend

    4 Global Phage Therapy Market Size by Regions

    • 4.1 Global Phage Therapy Revenue and Market Share by Regions
    • 4.2 North America Phage Therapy Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Phage Therapy Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Phage Therapy Revenue and Growth Rate (2014-2019)
    • 4.5 South America Phage Therapy Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Phage Therapy Revenue and Growth Rate (2014-2019)

    5 North America Phage Therapy Revenue by Countries

    • 5.1 North America Phage Therapy Revenue by Countries (2014-2019)
    • 5.2 USA Phage Therapy Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Phage Therapy Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Phage Therapy Revenue and Growth Rate (2014-2019)

    6 Europe Phage Therapy Revenue by Countries

    • 6.1 Europe Phage Therapy Revenue by Countries (2014-2019)
    • 6.2 Germany Phage Therapy Revenue and Growth Rate (2014-2019)
    • 6.3 UK Phage Therapy Revenue and Growth Rate (2014-2019)
    • 6.4 France Phage Therapy Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Phage Therapy Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Phage Therapy Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Phage Therapy Revenue by Countries

    • 7.1 Asia-Pacific Phage Therapy Revenue by Countries (2014-2019)
    • 7.2 China Phage Therapy Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Phage Therapy Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Phage Therapy Revenue and Growth Rate (2014-2019)
    • 7.5 India Phage Therapy Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Phage Therapy Revenue and Growth Rate (2014-2019)

    8 South America Phage Therapy Revenue by Countries

    • 8.1 South America Phage Therapy Revenue by Countries (2014-2019)
    • 8.2 Brazil Phage Therapy Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Phage Therapy Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Phage Therapy Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Phage Therapy by Countries

    • 9.1 Middle East and Africa Phage Therapy Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Phage Therapy Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Phage Therapy Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Phage Therapy Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Phage Therapy Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Phage Therapy Revenue and Growth Rate (2014-2019)

    10 Global Phage Therapy Market Segment by Type

    • 10.1 Global Phage Therapy Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Phage Therapy Market Forecast by Type (2019-2024)
    • 10.3 Oral Revenue Growth Rate (2014-2024)
    • 10.4 External Application Revenue Growth Rate (2014-2024)
    • 10.5 Surgical Treatment Revenue Growth Rate (2014-2024)

    11 Global Phage Therapy Market Segment by Application

    • 11.1 Global Phage Therapy Revenue Market Share by Application (2014-2019)
    • 11.2 Phage Therapy Market Forecast by Application (2019-2024)
    • 11.3 Human Medicine Revenue Growth (2014-2019)
    • 11.4 Veterinary Science Revenue Growth (2014-2019)
    • 11.5 Agriculture Revenue Growth (2014-2019)

    12 Global Phage Therapy Market Size Forecast (2019-2024)

    • 12.1 Global Phage Therapy Market Size Forecast (2019-2024)
    • 12.2 Global Phage Therapy Market Forecast by Regions (2019-2024)
    • 12.3 North America Phage Therapy Revenue Market Forecast (2019-2024)
    • 12.4 Europe Phage Therapy Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Phage Therapy Revenue Market Forecast (2019-2024)
    • 12.6 South America Phage Therapy Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Phage Therapy Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Phage therapy or viral phage therapy is the therapeutic use of bacteriophages to treat pathogenic bacterial infections.[1] Phage therapy has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

      Scope of the Report:
      The global Phage Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Phage Therapy.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Phage Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Phage Therapy market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Phage International
      Adaptive Phage Therapeutics
      AmpliPhi Biosciences
      C3J Therapeutics
      Enbiotix
      InnoPhage
      iNtODEWorld
      Intralytix
      Locus Biosciences
      Phagomed
      Pherecydes Pharma
      TechnoPhage
      Eligo Bioscience
      Phagelux

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Oral
      External Application
      Surgical Treatment

      Market Segment by Applications, can be divided into
      Human Medicine
      Veterinary Science
      Agriculture

      Buy now